Liver Dysfunction in COVID-19: From Onset to Recovery

Area of Science:

• Hepatology
• Infectious Diseases
• Pathology

Background:

• Coronavirus disease 2019 (COVID-19) has emerged globally, with increasing attention on extrapulmonary manifestations like liver dysfunction.
• The precise mechanisms, prevalence, and clinical impact of COVID-19-associated liver injury remain incompletely understood and debated.
• Existing studies report widely varying prevalence rates and controversial outcomes regarding liver dysfunction in COVID-19 patients.

Purpose of the Study:

• To review and analyze pathological and laboratory findings related to COVID-19-induced liver injury.
• To elucidate the potential mechanisms of liver damage from the onset of illness through recovery.
• To clarify the prevalence and clinical significance of liver dysfunction in the context of COVID-19.

Main Methods:

• Systematic review and analysis of pathological and laboratory data.
• Categorization of liver damage patterns based on histological findings.
• Evaluation of the relationship between liver dysfunction and clinical outcomes.

Main Results:

• Four distinct patterns of COVID-19-related liver damage were identified: hypoxemia/shock, vascular thrombosis/damage, bile duct issues, and other histological changes.
• Using a strict definition, the actual prevalence of liver dysfunction was lower than previously reported.
• Liver dysfunction demonstrated improvement during the recovery phase in most patients.

Conclusions:

• COVID-19-induced liver injury can manifest through several pathological mechanisms.
• A precise definition reveals a lower prevalence of liver dysfunction than often cited.
• Confirmed liver dysfunction, though often reversible, is a significant indicator of a severe clinical course in COVID-19 patients.